U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

ERX9848727: NextSeq 500 paired end sequencing; Ribo-seq in Escherichia coli MG1655 treated withTetracycline and Tylosin
4 ILLUMINA (NextSeq 500) runs: 17.9M spots, 1.5G bases, 529.9Mb downloads

Design: Ribo-seq in Escherichia coli MG1655 treated withTetracycline and Tylosin
Submitted by: The Wadsworth Center/NYSDOH
Study: Ribo-seq in Escherichia coli MG1655 treated withTetracycline and Tylosin
show Abstracthide Abstract
Ribo-seq was performed on cells treated with Tetracycline and Tylosin to to investigate the effect on ribosome pausing across the transcriptome of Escherichia coli MG1655.
Sample: tetracycline-1
SAMEA111436934 • ERS13530608 • All experiments • All runs
Library:
Name: tetracycline-1_p
Instrument: NextSeq 500
Strategy: OTHER
Source: GENOMIC
Selection: PCR
Layout: PAIRED
Construction protocol: Cultures were filtered at 17 min post-treatment. 200 ml of cells were grown in LB medium until OD600~1.1. One set of cultures was left untreated, other sets were treated with 1 μg/ml tetracycline or 400 μg/ml tylosin. Monosomes were isolated as previously described (Smith et al 2019 biorXiv) Library was constructed as previously described (Smith et al 2019 biorXiv) with minor modification: 3' linked oligonucleotide ligation reaction was carried overnight at 16oC. Circularized, reverse-transcribed cDNA was PCR-amplified for 6-8 cycles using primers containing Illumina sequencing indices
Experiment attributes:
Experimental Factor: compound: tetracycline
Experimental Factor: dose: 1
Runs: 4 runs, 17.9M spots, 1.5G bases, 529.9Mb
Run# of Spots# of BasesSizePublished
ERR103138224,423,810376.5M130.9Mb2022-10-16
ERR103138234,459,633379.5M132.2Mb2022-10-16
ERR103138244,506,527383.5M133.5Mb2022-10-16
ERR103138254,485,937381.8M133.2Mb2022-10-16

ID:
24845178

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...